AI In Life Science Analytics Market Size 2025-2029
The ai in life science analytics market size is forecast to increase by USD 16.5 billion, at a CAGR of 39.3% between 2024 and 2029.
The global AI in life science analytics market is driven by the economic imperative to improve R&D efficiency. Leveraging artificial intelligence in drug discovery, companies accelerate the earliest stages of therapeutic invention, using predictive algorithms to identify novel drug targets and design molecules in silico. The emergence of generative AI is a defining trend, enabling the creation of new chemical entities with unprecedented speed. This computational-first approach significantly reduces resources spent on non-viable candidates. Applying generative ai in life sciences and ai in genomics helps de-risk development and shorten discovery timelines, addressing a core strategic need for pharmaceutical and biotechnology firms to improve financial returns on research investment.While the potential is significant, the market's expansion is constrained by complex data governance and fragmentation. The life sciences sector's reliance on sensitive information, such as protected health information and clinical trial results, means AI algorithm training is subject to strict, evolving privacy regulations. These rules can stifle innovation by limiting data availability. A key challenge is the high initial investment required for computational infrastructure and talent, coupled with an uncertain return on investment. This is a considerable hurdle for smaller firms, restraining broader market adoption of ai in precision medicine and other advanced applications like ai in omics studies.
What will be the Size of the AI In Life Science Analytics Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019 - 2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
The market continues its evolution with a deepening integration of AI-driven diagnostics and predictive toxicology models into standard workflows. The use of generative ai in healthcare is expanding beyond research, with applications in creating synthetic control arms for clinical trials and optimizing preclinical study designs. This shift reflects a broader industry move toward data-driven decision-making, where real-world evidence analytics and computational biology tools are essential for maintaining a competitive edge and accelerating therapeutic invention.Advancements are also centered on improving the operational aspects of research and patient care. The application of life sciences analytics is critical for pharmacovigilance automation and streamlining regulatory submissions. Concurrently, there is a growing focus on ethical considerations, with efforts concentrated on algorithmic bias mitigation and developing explainable AI (XAI) to ensure transparency in clinical decision support systems. These developments indicate a maturing market where efficiency, accuracy, and trustworthiness are paramount for sustainable progress and broader adoption of artificial intelligence in biotechnology.
How is this AI In Life Science Analytics Industry segmented?
The ai in life science analytics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019 - 2023 for the following segments.
- Component
- Deployment
- End-user
- Pharmaceutical
- Healthcare
- Biotechnology
- Others
- Geography
- North America
- Europe
- Germany
- UK
- France
- Italy
- The Netherlands
- Spain
- APAC
- China
- Japan
- India
- Australia
- South Korea
- Indonesia
- South America
- Middle East and Africa
- Rest of World (ROW)
By Component Insights
The software segment is estimated to witness significant growth during the forecast period.
The software component is the core engine of the AI in life science analytics market, encompassing the algorithms, platforms, and tools for data analysis and process automation. This segment is defined by rapid innovation, driven by advancements in machine learning, deep learning, and generative AI. The software landscape is diverse, ranging from comprehensive, end-to-end platforms for the entire drug development lifecycle to specialized point solutions for challenges like medical imaging analysis, genomic data interpretation, or clinical trial patient matching.
A significant development is the creation of AI platforms that serve as foundational infrastructure for research. Major technology firms are introducing specialized software suites to empower the industry with cloud-based tools for drug discovery and bioinformatics. While mature markets dominate, regions contributing over 6.16% to the market opportunity are also seeing increased adoption of these AI software solutions to foster local innovation. Pharmaceutical companies are also becoming key software developers, creating collaborative ecosystems to advance industry-wide progress in predictive and precise healthcare approaches.
Request Free Sample
The Software segment was valued at USD 837.60 million in 2019 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 37.3% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
Request Free Sample
North America holds the largest share of the global artificial intelligence in life science analytics market. This dominance is due to its advanced technological infrastructure, a robust and well-funded healthcare ecosystem, and a high concentration of leading pharmaceutical companies, biotechnology innovators, and specialized AI technology providers. The region's growth is sustained by significant and continuous investment in research and development from both private and public sectors. The vibrant venture capital landscape provides crucial funding for startups pioneering novel AI applications.
A key factor in the North America market is the proactive and collaborative environment between large pharmaceutical corporations and agile AI-focused technology firms. These partnerships are instrumental in accelerating the translation of AI-powered insights into tangible therapeutic advancements. With software components representing over 72.8% of the market, the region's focus on technology development is clear. Furthermore, supportive regulatory bodies that acknowledge the transformative potential of AI in drug development help to de-risk the adoption of novel methodologies, encouraging further innovation and investment.
Market Dynamics
Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The global AI in life science analytics market is experiencing unprecedented growth, driven by the transformative potential of AI for accelerating drug discovery. Innovations like generative AI in molecule design and advanced AI models for protein engineering are revolutionizing early-stage development. Furthermore, the application of machine learning for clinical trials is streamlining processes, while predictive analytics in pharmacology offers deeper insights into drug efficacy. Key AI applications in biotechnology R&D include using AI for biomarker discovery and leveraging specialized AI platforms for genomic research. These technologies are crucial for generating robust insights and utilizing AI in real-world evidence generation. A significant focus is also on employing AI to reduce clinical trial attrition, making drug development more efficient and cost-effective.The market's expansion is further fueled by a focus on patient outcomes and data security. The application of AI analytics for personalized medicine is becoming standard practice, supported by breakthroughs in deep learning in medical imaging for more accurate diagnostics. The integration of natural language processing for EHR unlocks valuable unstructured data, while automating regulatory compliance with AI addresses critical operational challenges. To improve trial success, companies are optimizing patient recruitment with AI. Protecting patient privacy is paramount, leading to the adoption of federated learning for healthcare data. Advanced AI algorithms for disease progression and the use of a digital twin for clinical simulation are enhancing predictive capabilities. Moreover, synthetic data generation for healthcare and specialized tools for AI for rare disease diagnosis are opening new frontiers in medical research and patient care.
What are the key market drivers leading to the rise in the adoption of AI In Life Science Analytics Industry?
- The imperative for improved operational efficiency and predictive maintenance is a significant factor driving market growth.
The persistent economic pressure on the pharmaceutical industry to enhance the efficiency of its research and development pipeline is a primary market driver. The traditional path to market for a new therapeutic is marked by extreme costs and protracted timelines, with high failure rates in clinical trials. AI analytics provides a paradigm-shifting solution by leveraging predictive algorithms and generative models to accelerate the initial stages of drug discovery. These platforms identify and validate novel biological targets by analyzing vast, disparate datasets far beyond human scale. Generative AI is now applied to design novel molecules in silico, predicting chemical properties and potential toxicity before laboratory synthesis. This computational-first approach minimizes wasted resources on non-viable candidates, de-risking development and improving the financial return on R&D investment.The growth of the market is intrinsically connected to the concurrent explosions in biological data generation and the computational power needed to process it. Modern life sciences research produces data of unprecedented volume and complexity, including massive datasets from genomics, proteomics, and real-world evidence from electronic health records. This heterogeneous data contains critical insights but has surpassed the capacity of traditional statistical methods. Artificial intelligence, particularly machine learning and deep learning, is the essential technology for deriving meaning from this data deluge. AI models identify subtle patterns across these data types to uncover new disease pathways and predictive biomarkers. A significant portion of market opportunity, approximately 37.28%, is concentrated in geographies with advanced computational infrastructure and data-rich healthcare ecosystems, which provide the raw material for AI-driven innovation.
What are the market trends shaping the AI In Life Science Analytics Industry?
- The emergence of generative AI and industrial copilots is a key upcoming trend shaping the market landscape.
The technology's profound impact on accelerating drug discovery and development timelines is a key market driver. Traditionally, pharmaceutical R&D is characterized by long durations and high attrition rates. Artificial intelligence, particularly generative ai in healthcare, is reshaping this paradigm by introducing unprecedented efficiency into the earliest stages of therapeutic invention. By analyzing vast biological datasets, AI algorithms identify novel drug targets, predict molecular interactions, and design new chemical entities at a speed unattainable through conventional methods. This not only shortens the discovery phase but also increases the probability of success for drug candidates. The market is witnessing a surge in strategic collaborations between established pharmaceutical corporations and specialized AI technology firms, indicating a clear industry commitment to integrating these advanced analytical tools and using life science software.The market is also being propelled by the increasing focus on personalized medicine, an approach that tailors medical treatment to the individual characteristics of each patient. This paradigm shift relies heavily on the ability to analyze massive and complex datasets, particularly from ai in genomics and multi-omics studies, to understand disease at a molecular level. Artificial intelligence is uniquely positioned to meet this analytical challenge, offering powerful tools to decipher the intricate relationships between an individual's genetic makeup and their disease susceptibility. AI algorithms can identify subtle patterns and genetic biomarkers within these vast datasets that are impossible for human researchers to detect, enabling the development of highly targeted therapies and diagnostic tools. In regions contributing over 25.9% of the market opportunity, mature healthcare systems are actively integrating these tools to advance patient stratification and customized treatment strategies.
What challenges does the AI In Life Science Analytics Industry face during its growth?
- High initial investment costs and the uncertainty of return on investment present a major challenge to market expansion.
A primary challenge constraining market growth is the complex and fragmented landscape of data governance. The life sciences sector operates on highly sensitive information, including protected health information and proprietary clinical trial results. Using this data to train and validate artificial intelligence algorithms is subject to rigorous and evolving privacy and security regulations that vary significantly across major markets. In some regions, strict data handling standards and the potential for severe financial penalties for breaches foster a cautious approach to data sharing, which can stifle innovation by limiting the volume and diversity of data available for model training. Furthermore, many healthcare providers rely on legacy IT systems that were not designed for modern data interoperability, creating data silos that are technically difficult and costly to integrate for large-scale analytics.A second formidable challenge is the ambiguous, rapidly evolving, and regionally divergent regulatory and ethical framework. Life science companies must navigate a complex web of guidelines that often lag behind the pace of technological innovation, creating uncertainty and investment risk. In some jurisdictions, new legislation categorizes many AI applications in diagnostics and drug discovery as high-risk, triggering extensive obligations for conformity assessments and post-market monitoring. Industry stakeholders express concern that the complexity and potential for regulatory ambiguity could increase operational costs and lengthen approval timelines. This issue is particularly acute in geographies with a patchwork of national rules, such as those that constitute over 26.36% of the market opportunity, which complicates cross-border data collaborations essential for developing robust and generalizable AI models.
Exclusive Customer Landscape
The ai in life science analytics market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the ai in life science analytics market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, ai in life science analytics market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Atomwise Inc. - Offerings in the market encompass AI-powered analytics solutions, such as deep learning platforms, designed to predict molecular interactions and streamline commercial operations in the life sciences sector. These include cloud-based software for optimizing sales and marketing activities, as well as tools for remote patient monitoring through digital therapeutics. The solutions leverage predictive analytics to generate patient journey insights and utilize AI-powered imaging for enhanced diagnostics. Key capabilities extend to machine learning platforms that process complex data from electronic health records and genome sequencers, along with natural language processing tools for analyzing unstructured text from clinical trial documentation and medical literature.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Atomwise Inc.
- Axtria, Inc.
- BenevolentAI
- Biofourmis Inc.
- Clarify Health Solutions Inc.
- ConcertAI Inc.
- CureMetrix Inc.
- Databricks Inc.
- Deep Genomics Inc.
- Exscientia PLC
- Flatiron Health
- International Business Machines Corp.
- Iktos
- IQVIA Holdings Inc.
- Lexalytics Inc.
- PathAI Inc.
- SAS Institute Inc.
- Sorcero Inc.
- Tempus Labs Inc.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Ai In Life Science Analytics Market
In May 2024, Sanofi announced a collaboration with OpenAI and Formation Bio to build and deploy custom AI-powered software designed to accelerate processes across the entire drug development lifecycle.In May 2024, Databricks announced a partnership with TetraScience to deliver an AI-ready scientific data pipeline in the cloud, helping life science organizations prepare their data for advanced analytics and machine learning applications.In February 2024, PathAI announced an expanded exclusive relationship with Roche Tissue Diagnostics to advance AI-enabled interpretation for companion diagnostics.In January 2024, ConcertAI announced an expanded multi-year partnership with Bristol Myers Squibb to advance AI-powered oncology research and development using real-world data.
Research Analyst Overview
The global AI in life science analytics market is experiencing a significant transformation as computational approaches redefine therapeutic invention. The integration of generative chemistry platforms and in silico drug design is accelerating small molecule discovery and drug target identification. Advanced protein structure prediction and predictive toxicology models are enabling more effective preclinical study optimization and hit-to-lead optimization. The application of AI in genomics, supported by sophisticated computational biology tools, facilitates deep multi-omics data integration. This allows researchers to leverage drug repurposing analytics more effectively, uncovering new indications for existing compounds and streamlining the path from initial concept to viable drug candidate, reflecting a shift toward data-centric methodologies.Simultaneously, the clinical phase is reshaped through clinical trial optimization and the use of patient stratification algorithms. The adoption of synthetic control arms and support for decentralized clinical trials enhance efficiency, with industry adoption of AI in trial design expected to expand by over 45% in the coming years. Real-world evidence analytics and remote patient monitoring provide continuous data streams, while digital biomarker discovery offers new endpoints. Tools like AI-powered pathology and natural language processing for genomic data interpretation improve diagnostic accuracy. Addressing operational complexities involves implementing AI governance frameworks, ensuring data interoperability standards, and performing rigorous AI model validation. Techniques such as federated learning models, explainable AI (XAI), and algorithmic bias mitigation are essential for ensuring fairness in AI models, particularly in pharmacovigilance automation and regulatory submission automation.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled AI In Life Science Analytics Market insights. See full methodology.
|
Market Scope
|
|
Report Coverage
|
Details
|
|
Page number
|
296
|
|
Base year
|
2024
|
|
Historic period
|
2019 - 2023 |
|
Forecast period
|
2025-2029
|
|
Growth momentum & CAGR
|
Accelerating at a CAGR of 39.3%
|
|
Market growth 2024-2029
|
USD 16.5 billion
|
|
Market structure
|
Fragmented
|
|
YoY growth 2024-2029(%)
|
31.9%
|
|
Key countries
|
US, Canada, Mexico, Germany, UK, France, Italy, The Netherlands, Spain, China, Japan, India, Australia, South Korea, Indonesia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, South Africa, Israel, Turkey
|
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
|
Request Free Sample
What are the Key Data Covered in this AI In Life Science Analytics Market Research and Growth Report?
- CAGR of the AI In Life Science Analytics industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2024 and 2029
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, APAC, South America, Middle East and Africa
- Thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the ai in life science analytics market growth of industry companies
We can help! Our analysts can customize this ai in life science analytics market research report to meet your requirements.
Get in touch
1 Executive Summary
- 1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Component
- Executive Summary - Chart on Market Segmentation by Deployment
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Chart on Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Chart on Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Chart on Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3 Market Landscape
- 3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Chart on Market characteristics analysis
- 3.3 Value chain analysis
- Chart on Value chain analysis
4 Market Sizing
- 4 Market Sizing
- 4.1 Market definition
- Data Table on Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5 Historic Market Size
- 5.1 Global AI In Life Science Analytics Market 2019 - 2023
- Historic Market Size - Data Table on Global AI In Life Science Analytics Market 2019 - 2023 ($ billion)
- 5.2 Component segment analysis 2019 - 2023
- Historic Market Size - Component Segment 2019 - 2023 ($ billion)
- 5.3 Deployment segment analysis 2019 - 2023
- Historic Market Size - Deployment Segment 2019 - 2023 ($ billion)
- 5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Five Forces Analysis
- 6 Five Forces Analysis
- 6.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 6.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 6.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 6.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 6.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 6.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 6.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
7 Market Segmentation by Component
- 7 Market Segmentation by Component
- 7.1 Market segments
- Chart on Component - Market share 2024-2029 (%)
- Data Table on Component - Market share 2024-2029 (%)
- 7.2 Comparison by Component
- Chart on Comparison by Component
- Data Table on Comparison by Component
- 7.3 Software - Market size and forecast 2024-2029
- Chart on Software - Market size and forecast 2024-2029 ($ billion)
- Data Table on Software - Market size and forecast 2024-2029 ($ billion)
- Chart on Software - Year-over-year growth 2024-2029 (%)
- Data Table on Software - Year-over-year growth 2024-2029 (%)
- 7.4 Services - Market size and forecast 2024-2029
- Chart on Services - Market size and forecast 2024-2029 ($ billion)
- Data Table on Services - Market size and forecast 2024-2029 ($ billion)
- Chart on Services - Year-over-year growth 2024-2029 (%)
- Data Table on Services - Year-over-year growth 2024-2029 (%)
- 7.5 Market opportunity by Component
- Market opportunity by Component ($ billion)
- Data Table on Market opportunity by Component ($ billion)
8 Market Segmentation by Deployment
- 8 Market Segmentation by Deployment
- 8.1 Market segments
- Chart on Deployment - Market share 2024-2029 (%)
- Data Table on Deployment - Market share 2024-2029 (%)
- 8.2 Comparison by Deployment
- Chart on Comparison by Deployment
- Data Table on Comparison by Deployment
- 8.3 Cloud-based - Market size and forecast 2024-2029
- Chart on Cloud-based - Market size and forecast 2024-2029 ($ billion)
- Data Table on Cloud-based - Market size and forecast 2024-2029 ($ billion)
- Chart on Cloud-based - Year-over-year growth 2024-2029 (%)
- Data Table on Cloud-based - Year-over-year growth 2024-2029 (%)
- 8.4 On-premises - Market size and forecast 2024-2029
- Chart on On-premises - Market size and forecast 2024-2029 ($ billion)
- Data Table on On-premises - Market size and forecast 2024-2029 ($ billion)
- Chart on On-premises - Year-over-year growth 2024-2029 (%)
- Data Table on On-premises - Year-over-year growth 2024-2029 (%)
- 8.5 Market opportunity by Deployment
- Market opportunity by Deployment ($ billion)
- Data Table on Market opportunity by Deployment ($ billion)
9 Market Segmentation by End-user
- 9 Market Segmentation by End-user
- 9.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 9.3 Pharmaceutical - Market size and forecast 2024-2029
- Chart on Pharmaceutical - Market size and forecast 2024-2029 ($ billion)
- Data Table on Pharmaceutical - Market size and forecast 2024-2029 ($ billion)
- Chart on Pharmaceutical - Year-over-year growth 2024-2029 (%)
- Data Table on Pharmaceutical - Year-over-year growth 2024-2029 (%)
- 9.4 Healthcare - Market size and forecast 2024-2029
- Chart on Healthcare - Market size and forecast 2024-2029 ($ billion)
- Data Table on Healthcare - Market size and forecast 2024-2029 ($ billion)
- Chart on Healthcare - Year-over-year growth 2024-2029 (%)
- Data Table on Healthcare - Year-over-year growth 2024-2029 (%)
- 9.5 Biotechnology - Market size and forecast 2024-2029
- Chart on Biotechnology - Market size and forecast 2024-2029 ($ billion)
- Data Table on Biotechnology - Market size and forecast 2024-2029 ($ billion)
- Chart on Biotechnology - Year-over-year growth 2024-2029 (%)
- Data Table on Biotechnology - Year-over-year growth 2024-2029 (%)
- 9.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 9.7 Market opportunity by End-user
- Market opportunity by End-user ($ billion)
- Data Table on Market opportunity by End-user ($ billion)
10 Customer Landscape
- 10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
- 11 Geographic Landscape
- 11.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 11.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- 11.3.1 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 11.3.2 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 11.3.3 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ billion)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ billion)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- 11.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- 11.4.1 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 11.4.2 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 11.4.3 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 11.4.4 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 11.4.5 The Netherlands - Market size and forecast 2024-2029
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
- 11.4.6 Spain - Market size and forecast 2024-2029
- Chart on Spain - Market size and forecast 2024-2029 ($ billion)
- Data Table on Spain - Market size and forecast 2024-2029 ($ billion)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
- 11.5 APAC - Market size and forecast 2024-2029
- Chart on APAC - Market size and forecast 2024-2029 ($ billion)
- Data Table on APAC - Market size and forecast 2024-2029 ($ billion)
- Chart on APAC - Year-over-year growth 2024-2029 (%)
- Data Table on APAC - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - APAC
- Data Table on Regional Comparison - APAC
- 11.5.1 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 11.5.2 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 11.5.3 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 11.5.4 Australia - Market size and forecast 2024-2029
- Chart on Australia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Australia - Market size and forecast 2024-2029 ($ billion)
- Chart on Australia - Year-over-year growth 2024-2029 (%)
- Data Table on Australia - Year-over-year growth 2024-2029 (%)
- 11.5.5 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 11.5.6 Indonesia - Market size and forecast 2024-2029
- Chart on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Chart on Indonesia - Year-over-year growth 2024-2029 (%)
- Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
- 11.6 South America - Market size and forecast 2024-2029
- Chart on South America - Market size and forecast 2024-2029 ($ billion)
- Data Table on South America - Market size and forecast 2024-2029 ($ billion)
- Chart on South America - Year-over-year growth 2024-2029 (%)
- Data Table on South America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - South America
- Data Table on Regional Comparison - South America
- 11.6.1 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 11.6.2 Argentina - Market size and forecast 2024-2029
- Chart on Argentina - Market size and forecast 2024-2029 ($ billion)
- Data Table on Argentina - Market size and forecast 2024-2029 ($ billion)
- Chart on Argentina - Year-over-year growth 2024-2029 (%)
- Data Table on Argentina - Year-over-year growth 2024-2029 (%)
- 11.6.3 Colombia - Market size and forecast 2024-2029
- Chart on Colombia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Colombia - Market size and forecast 2024-2029 ($ billion)
- Chart on Colombia - Year-over-year growth 2024-2029 (%)
- Data Table on Colombia - Year-over-year growth 2024-2029 (%)
- 11.7 Middle East and Africa - Market size and forecast 2024-2029
- Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ billion)
- Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ billion)
- Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
- Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Middle East and Africa
- Data Table on Regional Comparison - Middle East and Africa
- 11.7.1 Saudi Arabia - Market size and forecast 2024-2029
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- 11.7.2 UAE - Market size and forecast 2024-2029
- Chart on UAE - Market size and forecast 2024-2029 ($ billion)
- Data Table on UAE - Market size and forecast 2024-2029 ($ billion)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- 11.7.3 South Africa - Market size and forecast 2024-2029
- Chart on South Africa - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Africa - Market size and forecast 2024-2029 ($ billion)
- Chart on South Africa - Year-over-year growth 2024-2029 (%)
- Data Table on South Africa - Year-over-year growth 2024-2029 (%)
- 11.7.4 Israel - Market size and forecast 2024-2029
- Chart on Israel - Market size and forecast 2024-2029 ($ billion)
- Data Table on Israel - Market size and forecast 2024-2029 ($ billion)
- Chart on Israel - Year-over-year growth 2024-2029 (%)
- Data Table on Israel - Year-over-year growth 2024-2029 (%)
- 11.7.5 Turkey - Market size and forecast 2024-2029
- Chart on Turkey - Market size and forecast 2024-2029 ($ billion)
- Data Table on Turkey - Market size and forecast 2024-2029 ($ billion)
- Chart on Turkey - Year-over-year growth 2024-2029 (%)
- Data Table on Turkey - Year-over-year growth 2024-2029 (%)
- 11.8 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)
12 Drivers, Challenges, and Opportunity
- 12 Drivers, Challenges, and Opportunity
- 12.1 Market drivers
- Imperative for enhanced operational efficiency and predictive maintenance
- Proliferation of industrial internet of things and big data analytics
- Addressing skilled labor shortage and enhancing worker safety
- 12.2 Market challenges
- High initial investment and uncertain return on investment
- Data integration complexity and cybersecurity vulnerabilities
- Scarcity of skilled talent and need for workforce upskilling
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 12.4 Market opportunities
- Emergence of generative AI and industrial copilots
- Proliferation of edge AI and on-device processing
- Integration of AI with digital twins for advanced simulation
13 Competitive Landscape
- 13 Competitive Landscape
- 13.1 Overview
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
14 Competitive Analysis
- 14 Competitive Analysis
- 14.1 Companies profiled
- 14.2 Company ranking index
- 14.3 Market positioning of companies
- Matrix on companies position and classification
- 14.4 Atomwise Inc.
- Atomwise Inc. - Overview
- Atomwise Inc. - Product / Service
- Atomwise Inc. - Key offerings
- SWOT
- 14.5 Axtria, Inc.
- Axtria, Inc. - Overview
- Axtria, Inc. - Product / Service
- Axtria, Inc. - Key offerings
- SWOT
- 14.6 Biofourmis Inc.
- Biofourmis Inc. - Overview
- Biofourmis Inc. - Product / Service
- Biofourmis Inc. - Key offerings
- SWOT
- 14.7 Clarify Health Solutions Inc.
- Clarify Health Solutions Inc. - Overview
- Clarify Health Solutions Inc. - Product / Service
- Clarify Health Solutions Inc. - Key offerings
- SWOT
- 14.8 CureMetrix Inc.
- CureMetrix Inc. - Overview
- CureMetrix Inc. - Product / Service
- CureMetrix Inc. - Key offerings
- SWOT
- 14.9 Databricks Inc.
- Databricks Inc. - Overview
- Databricks Inc. - Product / Service
- Databricks Inc. - Key offerings
- SWOT
- 14.10 Deep Genomics Inc.
- Deep Genomics Inc. - Overview
- Deep Genomics Inc. - Product / Service
- Deep Genomics Inc. - Key offerings
- SWOT
- 14.11 Exscientia PLC
- Exscientia PLC - Overview
- Exscientia PLC - Product / Service
- Exscientia PLC - Key offerings
- SWOT
- 14.12 International Business Machines Corp.
- International Business Machines Corp. - Overview
- International Business Machines Corp. - Business segments
- International Business Machines Corp. - Key news
- International Business Machines Corp. - Key offerings
- International Business Machines Corp. - Segment focus
- SWOT
- 14.13 Iktos
- Iktos - Overview
- Iktos - Product / Service
- Iktos - Key offerings
- SWOT
- 14.14 IQVIA Holdings Inc.
- IQVIA Holdings Inc. - Overview
- IQVIA Holdings Inc. - Business segments
- IQVIA Holdings Inc. - Key offerings
- IQVIA Holdings Inc. - Segment focus
- SWOT
- 14.15 Lexalytics Inc.
- Lexalytics Inc. - Overview
- Lexalytics Inc. - Product / Service
- Lexalytics Inc. - Key offerings
- SWOT
- 14.16 PathAI Inc.
- PathAI Inc. - Overview
- PathAI Inc. - Product / Service
- PathAI Inc. - Key offerings
- SWOT
- 14.17 SAS Institute Inc.
- SAS Institute Inc. - Overview
- SAS Institute Inc. - Product / Service
- SAS Institute Inc. - Key news
- SAS Institute Inc. - Key offerings
- SWOT
- 14.18 Sorcero Inc.
- Sorcero Inc. - Overview
- Sorcero Inc. - Product / Service
- Sorcero Inc. - Key offerings
- SWOT
15 Appendix
- 15 Appendix
- 15.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- 15.5 Data procurement
- 15.6 Data validation
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.8 Data synthesis
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations
INFORMATION SOURCES
DATA ANALYSIS
REPORT WRITING
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
